SMARCB1 and neoplasm: Based on our findings, the disease causing mutation is a de novo germline variant in SMARCB1, c.601C>T p.Arg201∗ occurring in the patient, that when combined with the somatic loss of the healthy allele leads to the complete loss of SMARCB1 function in the tumour cells.